Výsledky vyhledávání - "Gregory Brill"

Akademický článek

Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study

Autor: Eun Ha Kang, Yinzhu Jin, Gregory Brill, Jennifer Lewey, Elisabetta Patorno, Rishi J. Desai, Seoyoung C. Kim

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)

BackgroundWe examined the cardiovascular risk of abatacept compared with tumor necrosis factor (TNF) inhibitors in patients with rheumatoid arthritis with and without diabetes mellitus (DM). Methods and ResultsWe conducted a cohort study of patients

Externí odkaz: https://doaj.org/article/d1761182ea174dbf8a964d3e57b0bc21

Zobrazit plný text záznamu

Validation of obesity‐related diagnosis codes in claims data

Autor: Sebastian Schneeweiss, Karine Suissa, Kueiyu Joshua Lin, Elisabetta Patorno, Gregory Brill, Seoyoung C. Kim

Publikováno v: Diabetes Obes Metab

AIM To determine whether body mass index (BMI) can be accurately identified in epidemiological studies using claims databases. MATERIALS AND METHODS Using the Mass General Brigham Research Patient Data Repository-Medicare-linked database, we identifi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b78668c50d31ec07d4d5e52d055b3fc7
https://doi.org/10.1111/dom.14512

Zobrazit plný text záznamu

The Patterns of Use of Medications for Inflammatory Bowel Disease During Pregnancy in the US and Sweden Are Changing

Autor: Rishi J. Desai, Seoyoung C. Kim, Sonia Friedman, Krista F. Huybrechts, Gabriella Bröms, Gregory Brill, Mollie Wood, Brian T. Bateman, Sonia Hernandez-Diaz

Publikováno v: Inflammatory Bowel Diseases. 27:1427-1434

Background Population-level data spanning different countries describing oral and parenteral treatment in pregnant women with inflammatory bowel disease (IBD) are scarce. We studied treatment with sulfasalazine/5-aminosalicylates, corticosteroids, th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1282fe8a9d4695f53c5d65684b23eaaf
https://doi.org/10.1093/ibd/izaa294

Zobrazit plný text záznamu

Trends in Clinical Characteristics and Prescribing Preferences for SGLT2 Inhibitors and GLP-1 Receptor Agonists, 2013–2018

Autor: Gregory Brill, Deborah J. Wexler, Chintan V. Dave, Elisabetta Patorno, Sebastian Schneeweiss

Publikováno v: Diabetes Care

OBJECTIVE There is a paucity of data evaluating recent changes in clinical and prescriber characteristics of patients initiating sodium–glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide 1 receptor agonists (GLP-1RA). RESEARCH DE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63675d9e5195b7f996de423da7b2452a
https://doi.org/10.2337/dc19-1943

Zobrazit plný text záznamu

Antidiabetic medication use in commercially insured children and adolescents in the United States from 2004 to 2019

Autor: Brian T. Bateman, Gregory Brill, Florence T. Bourgeois, Sonia Hernandez-Diaz, Jenny W Sun, Sebastien Haneuse, Krista F. Huybrechts

Publikováno v: Diabetes, obesitymetabolismREFERENCES. 23(2)

AIM To describe the patterns of non-insulin antidiabetic medication use, initiation and adherence in the paediatric population. METHODS We conducted a descriptive study of non-insulin antidiabetic medication use in children and adolescents (aged 10-1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc7767af6549adf56d729de78b971e55
https://pubmed.ncbi.nlm.nih.gov/33118291

Zobrazit plný text záznamu

Association of Type of Oral Anticoagulant Dispensed With Adverse Clinical Outcomes in Patients Extending Anticoagulation Therapy Beyond 90 Days After Hospitalization for Venous Thromboembolism

Autor: Ajinkya Pawar, Joshua J. Gagne, Chandrasekar Gopalakrishnan, Geetha Iyer, Helen Tesfaye, Gregory Brill, Kristyn Chin, Katsiaryna Bykov

Publikováno v: JAMA

IMPORTANCE: Guidelines for managing venous thromboembolism (VTE) recommend at least 90 days of therapy with oral anticoagulants. Limited evidence exists about the optimal drug for continuing therapy beyond 90 days. OBJECTIVE: To compare having prescr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28d06185394d1f668910371d805caf94
https://doi.org/10.1001/jama.2022.1920

Zobrazit plný text záznamu

Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors

Autor: Alexis A. Krumme, Niteesh K. Choudhry, William H. Shrank, Julie C. Lauffenburger, Olga S. Matlin, Gregory Brill, Claire M. Spettell, Jessica M. Franklin

Publikováno v: Journal of Managed Care & Specialty Pharmacy. 24:469-477

Efforts at predicting long-term adherence to medications have been focused on patients filling typical month-long supplies of medication. However, prediction remains difficult for patients filling longer initial supplies, a practice that is becoming

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd57f69e2640733211ea3c983fcbad55
https://doi.org/10.18553/jmcp.2018.24.5.469

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání